Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism KRAS modulators(GTPase KRas modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | ES | 01 Jan 2022 | |
Uterine Neoplasms | Preclinical | ES | 01 Jan 2022 |